Table 1 Clinical and laboratory findings... | American Society of Hematology

Table 1

Clinical and laboratory findings for 356 newly diagnosed patients with the consensus panel diagnosis of WM presenting to the Dana-Farber Cancer Institute

	Median	Range	Normal reference range
Age, y	58	32-91	NA
Sex, male/female	215/141		NA
Bone marrow involvement, percentage	30	5-95	NA
Adenopathy, percentage	15		NA
Splenomegaly, percentage	10		NA
IgM, mg/dL	2620	270-12 400	40-230
IgG, mg/dL	674	80-2770	700-1600
IgA, mg/dL	58	6-438	70-400
Serum viscosity, cp	2.0	1.1-7.2	1.4-1.9
Hematocrit, percentage	35.4	17.2-45.4	34.8-43.6
Platelets, ×10⁹/L	275	42-675	155-410
White blood cells, ×10⁹/L	6.4	1.7-22	3.8-9.2
β-2 microglobulin, mg/dL	2.5	0.9-13.7	0-2.7
LDH, U/mL	313	61-1701	313-618

	Median	Range	Normal reference range
Age, y	58	32-91	NA
Sex, male/female	215/141		NA
Bone marrow involvement, percentage	30	5-95	NA
Adenopathy, percentage	15		NA
Splenomegaly, percentage	10		NA
IgM, mg/dL	2620	270-12 400	40-230
IgG, mg/dL	674	80-2770	700-1600
IgA, mg/dL	58	6-438	70-400
Serum viscosity, cp	2.0	1.1-7.2	1.4-1.9
Hematocrit, percentage	35.4	17.2-45.4	34.8-43.6
Platelets, ×10⁹/L	275	42-675	155-410
White blood cells, ×10⁹/L	6.4	1.7-22	3.8-9.2
β-2 microglobulin, mg/dL	2.5	0.9-13.7	0-2.7
LDH, U/mL	313	61-1701	313-618

NA indicates not applicable.